Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib in advanced oesophagogastric cancer
NCT03829345Phase 2Unknown
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jul 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in esophageal cancer, Gastroesophageal junction cancer (GEJC), gastric cancer (GC), sponsored by Royal Marsden NHS Foundation Trust. Status: unknown.
02
Drugs
olaparib
03
Conditions
esophageal cancerGastroesophageal junction cancer (GEJC)gastric cancer (GC)
Beyond the preview
Go deeper on NCT03829345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03829345.